JAZZ vs VSTD · P/E 1988, rev $4.07B vs rev $12.8M
Jazz Pharmaceuticals PLC (JAZZ) versus Vestand Inc. (VSTD) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Vestand Inc. (VSTD) is a restaurants company listed on NASDAQ.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported VSTD revenue for 2024-12-31 was $12.8M. Net income was -$2.7M. Revenue was up 39.3% from 2023-12-31 to 2024-12-31. VSTD currently screens at market cap $4.5M.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. VSTD currently screens at market cap $4.5M.
Not investment advice. Open the JAZZ and VSTD stock pages for the full models.
Not investment advice.